Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s11095-011-0625-0, but it redirected us to https://link.springer.com/article/10.1007/s11095-011-0625-0. The analysis below is for the second page.

Title[redir]:
Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model | Pharmaceutical Research
Description:
Purpose Deregulation of IGF signaling plays an important role in prostate cancer and contributes to invasion and metastasis. We determined the effect of apigenin, a plant flavone, on IGF signaling and its downstream targets in TRAMP mice. Methods Mice received p.o. apigenin at 20 and 50 μg/day dose for 20 weeks. ELISA, Western blotting and immunohistochemistry were performed to examine the IGF-axis and its regulated pathway in response to apigenin intake. Results Increased serum levels of IGF-I, VEGF, uPA and concomitant decrease in IGFBP-3 were observed; p-Akt (Ser473), p-ERK1 (T202/Y204) and p-ERK2 (T185/Y187) expression increased in the dorso-lateral prostate of TRAMP mice during the course of cancer progression as a function of age. P.o. administration of apigenin resulted in substantial reduction in the levels of IGF-I and increase in the levels of IGFBP-3 in the serum and the dorso-lateral prostate. This modulation of IGF/IGFBP-3 was associated with an inhibition of p-Akt and p-ERK1/2. Apigenin intake resulted in marked inhibition of VEGF, uPA, MMP-2 and MMP-9 which coincided with tumor growth inhibition and complete absence of metastasis in TRAMP mice. Conclusions Our results indicate that apigenin effectively suppressed prostate cancer progression in TRAMP mice by attenuating IGF-I/IGFBP-3 signaling and inhibiting angiogenesis and metastasis.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't see how the site brings in money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

cancer, article, prostate, google, scholar, pubmed, cas, growth, insulinlike, factor, apigenin, gupta, signaling, shukla, cell, res, mice, protein, research, metastasis, tramp, vegf, study, kinase, mouse, maclennan, receptor, usa, privacy, cookies, content, factori, model, sanjay, igf, intake, igfi, inhibition, angiogenesis, access, risk, int, case, cleveland, ohio, publish, search, autochthonous, pingfu, plant,

Topics {✒️}

growth factor-i-induced signaling month download article/chapter growth factor-binding protein-2 urokinase-type plasminogen activator protein-tyrosine kinase activity igf-binding protein-3 concentrations hypoxia-inducible factor-1-dependent related subjects pan-cancer analysis reveals autochthonous mouse model apigenin attenuates insulin wood research tower full article pdf growth factor-1 receptor protein kinase ck2 autochthonous prostate cancer growth factor axis privacy choices/manage cookies apigenin suppresses insulin benign prostatic hyperplasia human prostate cancer article shukla case–control study cell commun adhes prostate cancer detection prostate cancer cells author information authors natl cancer inst cancer metastasis rev dorso-lateral prostate prostate epithelium leads check access instant access prostate cancer risk phosphoinositide 3-kinase pathway cancer prev res prevent cancer foundation pi3k/akt pathway exp cell res dietary flavonoid intake clin endocrinol metab sanjay gupta european economic area 50 μg/day dose pharmacol exp ther food chem toxicol matrix-degrading proteases breast cancer risk growth factor growth factor 1

Questions {❓}

  • Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model
         description:Deregulation of IGF signaling plays an important role in prostate cancer and contributes to invasion and metastasis. We determined the effect of apigenin, a plant flavone, on IGF signaling and its downstream targets in TRAMP mice. Mice received p.o. apigenin at 20 and 50 μg/day dose for 20 weeks. ELISA, Western blotting and immunohistochemistry were performed to examine the IGF-axis and its regulated pathway in response to apigenin intake. Increased serum levels of IGF-I, VEGF, uPA and concomitant decrease in IGFBP-3 were observed; p-Akt (Ser473), p-ERK1 (T202/Y204) and p-ERK2 (T185/Y187) expression increased in the dorso-lateral prostate of TRAMP mice during the course of cancer progression as a function of age. P.o. administration of apigenin resulted in substantial reduction in the levels of IGF-I and increase in the levels of IGFBP-3 in the serum and the dorso-lateral prostate. This modulation of IGF/IGFBP-3 was associated with an inhibition of p-Akt and p-ERK1/2. Apigenin intake resulted in marked inhibition of VEGF, uPA, MMP-2 and MMP-9 which coincided with tumor growth inhibition and complete absence of metastasis in TRAMP mice. Our results indicate that apigenin effectively suppressed prostate cancer progression in TRAMP mice by attenuating IGF-I/IGFBP-3 signaling and inhibiting angiogenesis and metastasis.
         datePublished:2011-12-03T00:00:00Z
         dateModified:2011-12-03T00:00:00Z
         pageStart:1506
         pageEnd:1517
         sameAs:https://doi.org/10.1007/s11095-011-0625-0
         keywords:
            angiogenesis
            apigenin
            insulin-like growth factor
            metastasis
            prostate cancer
            Pharmacology/Toxicology
            Pharmacy
            Biochemistry
            general
            Medical Law
            Biomedical Engineering and Bioengineering
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig6_HTML.gif
         isPartOf:
            name:Pharmaceutical Research
            issn:
               1573-904X
               0724-8741
            volumeNumber:29
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sanjeev Shukla
               affiliation:
                     name:Case Western Reserve University
                     address:
                        name:Department of Urology, Case Western Reserve University, Cleveland, USA
                        type:PostalAddress
                     type:Organization
                     name:University Hospitals Case Medical Center
                     address:
                        name:University Hospitals Case Medical Center, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gregory T. MacLennan
               affiliation:
                     name:Case Western Reserve University
                     address:
                        name:Department of Pathology, Case Western Reserve University, Cleveland, USA
                        type:PostalAddress
                     type:Organization
                     name:University Hospitals Case Medical Center
                     address:
                        name:University Hospitals Case Medical Center, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pingfu Fu
               affiliation:
                     name:Case Western Reserve University
                     address:
                        name:Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, USA
                        type:PostalAddress
                     type:Organization
                     name:Case Comprehensive Cancer Center
                     address:
                        name:Case Comprehensive Cancer Center, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sanjay Gupta
               affiliation:
                     name:Case Western Reserve University
                     address:
                        name:Department of Urology, Case Western Reserve University, Cleveland, USA
                        type:PostalAddress
                     type:Organization
                     name:University Hospitals Case Medical Center
                     address:
                        name:University Hospitals Case Medical Center, Cleveland, USA
                        type:PostalAddress
                     type:Organization
                     name:Case Comprehensive Cancer Center
                     address:
                        name:Case Comprehensive Cancer Center, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Apigenin Attenuates Insulin-Like Growth Factor-I Signaling in an Autochthonous Mouse Prostate Cancer Model
      description:Deregulation of IGF signaling plays an important role in prostate cancer and contributes to invasion and metastasis. We determined the effect of apigenin, a plant flavone, on IGF signaling and its downstream targets in TRAMP mice. Mice received p.o. apigenin at 20 and 50 μg/day dose for 20 weeks. ELISA, Western blotting and immunohistochemistry were performed to examine the IGF-axis and its regulated pathway in response to apigenin intake. Increased serum levels of IGF-I, VEGF, uPA and concomitant decrease in IGFBP-3 were observed; p-Akt (Ser473), p-ERK1 (T202/Y204) and p-ERK2 (T185/Y187) expression increased in the dorso-lateral prostate of TRAMP mice during the course of cancer progression as a function of age. P.o. administration of apigenin resulted in substantial reduction in the levels of IGF-I and increase in the levels of IGFBP-3 in the serum and the dorso-lateral prostate. This modulation of IGF/IGFBP-3 was associated with an inhibition of p-Akt and p-ERK1/2. Apigenin intake resulted in marked inhibition of VEGF, uPA, MMP-2 and MMP-9 which coincided with tumor growth inhibition and complete absence of metastasis in TRAMP mice. Our results indicate that apigenin effectively suppressed prostate cancer progression in TRAMP mice by attenuating IGF-I/IGFBP-3 signaling and inhibiting angiogenesis and metastasis.
      datePublished:2011-12-03T00:00:00Z
      dateModified:2011-12-03T00:00:00Z
      pageStart:1506
      pageEnd:1517
      sameAs:https://doi.org/10.1007/s11095-011-0625-0
      keywords:
         angiogenesis
         apigenin
         insulin-like growth factor
         metastasis
         prostate cancer
         Pharmacology/Toxicology
         Pharmacy
         Biochemistry
         general
         Medical Law
         Biomedical Engineering and Bioengineering
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11095-011-0625-0/MediaObjects/11095_2011_625_Fig6_HTML.gif
      isPartOf:
         name:Pharmaceutical Research
         issn:
            1573-904X
            0724-8741
         volumeNumber:29
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sanjeev Shukla
            affiliation:
                  name:Case Western Reserve University
                  address:
                     name:Department of Urology, Case Western Reserve University, Cleveland, USA
                     type:PostalAddress
                  type:Organization
                  name:University Hospitals Case Medical Center
                  address:
                     name:University Hospitals Case Medical Center, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gregory T. MacLennan
            affiliation:
                  name:Case Western Reserve University
                  address:
                     name:Department of Pathology, Case Western Reserve University, Cleveland, USA
                     type:PostalAddress
                  type:Organization
                  name:University Hospitals Case Medical Center
                  address:
                     name:University Hospitals Case Medical Center, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pingfu Fu
            affiliation:
                  name:Case Western Reserve University
                  address:
                     name:Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, USA
                     type:PostalAddress
                  type:Organization
                  name:Case Comprehensive Cancer Center
                  address:
                     name:Case Comprehensive Cancer Center, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sanjay Gupta
            affiliation:
                  name:Case Western Reserve University
                  address:
                     name:Department of Urology, Case Western Reserve University, Cleveland, USA
                     type:PostalAddress
                  type:Organization
                  name:University Hospitals Case Medical Center
                  address:
                     name:University Hospitals Case Medical Center, Cleveland, USA
                     type:PostalAddress
                  type:Organization
                  name:Case Comprehensive Cancer Center
                  address:
                     name:Case Comprehensive Cancer Center, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Pharmaceutical Research
      issn:
         1573-904X
         0724-8741
      volumeNumber:29
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Case Western Reserve University
      address:
         name:Department of Urology, Case Western Reserve University, Cleveland, USA
         type:PostalAddress
      name:University Hospitals Case Medical Center
      address:
         name:University Hospitals Case Medical Center, Cleveland, USA
         type:PostalAddress
      name:Case Western Reserve University
      address:
         name:Department of Pathology, Case Western Reserve University, Cleveland, USA
         type:PostalAddress
      name:University Hospitals Case Medical Center
      address:
         name:University Hospitals Case Medical Center, Cleveland, USA
         type:PostalAddress
      name:Case Western Reserve University
      address:
         name:Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, USA
         type:PostalAddress
      name:Case Comprehensive Cancer Center
      address:
         name:Case Comprehensive Cancer Center, Cleveland, USA
         type:PostalAddress
      name:Case Western Reserve University
      address:
         name:Department of Urology, Case Western Reserve University, Cleveland, USA
         type:PostalAddress
      name:University Hospitals Case Medical Center
      address:
         name:University Hospitals Case Medical Center, Cleveland, USA
         type:PostalAddress
      name:Case Comprehensive Cancer Center
      address:
         name:Case Comprehensive Cancer Center, Cleveland, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sanjeev Shukla
      affiliation:
            name:Case Western Reserve University
            address:
               name:Department of Urology, Case Western Reserve University, Cleveland, USA
               type:PostalAddress
            type:Organization
            name:University Hospitals Case Medical Center
            address:
               name:University Hospitals Case Medical Center, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Gregory T. MacLennan
      affiliation:
            name:Case Western Reserve University
            address:
               name:Department of Pathology, Case Western Reserve University, Cleveland, USA
               type:PostalAddress
            type:Organization
            name:University Hospitals Case Medical Center
            address:
               name:University Hospitals Case Medical Center, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Pingfu Fu
      affiliation:
            name:Case Western Reserve University
            address:
               name:Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, USA
               type:PostalAddress
            type:Organization
            name:Case Comprehensive Cancer Center
            address:
               name:Case Comprehensive Cancer Center, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:Sanjay Gupta
      affiliation:
            name:Case Western Reserve University
            address:
               name:Department of Urology, Case Western Reserve University, Cleveland, USA
               type:PostalAddress
            type:Organization
            name:University Hospitals Case Medical Center
            address:
               name:University Hospitals Case Medical Center, Cleveland, USA
               type:PostalAddress
            type:Organization
            name:Case Comprehensive Cancer Center
            address:
               name:Case Comprehensive Cancer Center, Cleveland, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Urology, Case Western Reserve University, Cleveland, USA
      name:University Hospitals Case Medical Center, Cleveland, USA
      name:Department of Pathology, Case Western Reserve University, Cleveland, USA
      name:University Hospitals Case Medical Center, Cleveland, USA
      name:Department of Epidemiology & Biostatistics, Case Western Reserve University, Cleveland, USA
      name:Case Comprehensive Cancer Center, Cleveland, USA
      name:Department of Urology, Case Western Reserve University, Cleveland, USA
      name:University Hospitals Case Medical Center, Cleveland, USA
      name:Case Comprehensive Cancer Center, Cleveland, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(201)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

6.05s.